huAR9.6-IRDye800

N/A

Report date: 2024/07/02 09:51:53

Base Information

Drug NamehuAR9.6-IRDye800
Drug Alias NameAR9.6-IRDye800
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMucin-16 modulators
TargetsMucin-16
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Nebraska Medical Center
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A